H-1B & Green Card Salary Data and Market Analysis
Total Filings
All time (charts below use selected years)Median Salary
Across filings in selected periodTop Employers
Hiring This RoleSee all H-1B/PERM filings for this role →
| Employer | Filings | Median Salary | Salary Range | Approval Rate |
|---|---|---|---|---|
| Sarepta Therapeutics, Inc. | 4 | $121,000 | $95,000 - $131,000 | 100.0% |
| Accent Therapeutics | 1 | $108,420 | $108,420 - $108,420 | 100.0% |
| Cayman Chemical | 1 | $126,969 | $126,969 - $126,969 | 100.0% |
| Verve Therapeutics, Inc. | 1 | $115,000 | $115,000 - $115,000 | 100.0% |
| Experience Level | Filings | Median Salary | Salary Range |
|---|---|---|---|
| II | 3 | $121,000 | $121,000 - $126,969 |
| Unspecified | 1 | $115,000 | $115,000 - $115,000 |
| I | 1 | $95,000 | $95,000 - $95,000 |
| Lead | 1 | $108,420 | $108,420 - $108,420 |
| Senior | 1 | $131,000 | $131,000 - $131,000 |
| City | State | Filings | Median Salary |
|---|---|---|---|
| Bedford | MA | 2 | $126,000 |
| Cambridge | MA | 2 | $108,000 |
| Ann Arbor | MI | 1 | $126,969 |
| Boston | MA | 1 | $115,000 |
| Lexington | MA | 1 | $108,420 |
These roles are variations of Scientist II, Discovery Chemistry with different seniority levels.
| Role | Experience Level | Filings | Avg Salary |
|---|---|---|---|
| Scientist II, Discovery Chemistry | 3 | $122,990 | |
| SCIENTIST I, DISCOVERY CHEMISTRY | 2 | $101,060 | |
| Senior Scientist, Discovery Chemistry | 2 | $114,734 | |
| Scientist, Discovery Chemistry | Unspecified | 1 | $115,000 |
| Senior Scientist, Lead Discovery (Biochemistry) | 1 | $108,420 |
| Fiscal Year | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| 2023 | 3 | $108,420 | 100.0% |
| 2025 | 2 | $121,000 | 100.0% |
| 2026 | 2 | $128,985 | 100.0% |
Compare how top companies pay for this role.
| Company | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| Sarepta Therapeutics, Inc. | 4 | $121,000 | 100.0% |
| Accent Therapeutics | 1 | $108,420 | 100.0% |
| Cayman Chemical | 1 | $126,969 | 100.0% |
| Verve Therapeutics, Inc. | 1 | $115,000 | 100.0% |